Kimberly McCormick
General Counsel at MARINUS PHARMACEUTICALS, INC.
Network origin in Kimberly McCormick first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kimberly McCormick via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
I-Flow Corp.
I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Medical Specialties | Director/Board Member | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | General Counsel | |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Founder | |
JK Advisors, Inc. | Corporate Officer/Principal | ||
Dartmouth College | College/University | Undergraduate Degree | |
Ortho-McNeil Pharmaceutical LLC
Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Juniata College | College/University | Undergraduate Degree | |
US Military Academy | College/University | Undergraduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree | |
Philadelphia University | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
University of Maryland | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree | |
Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
University of Mumbai | College/University | Graduate Degree | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biomedical Sciences Careers Program, Inc. | Director/Board Member | ||
Biotrack, Inc. | Chief Operating Officer | ||
United Way of Greater Philadelphia & Southern New Jersey
United Way of Greater Philadelphia & Southern New Jersey Miscellaneous Commercial ServicesCommercial Services United Way of Greater Philadelphia & Southern New Jersey provides social services. It helps in education, financial stability and health sectors. The company was founded in 1921 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | General Counsel | |
Tabor Children's Services | Director/Board Member | ||
INVIVO THERAPEUTICS HOLDINGS CORP. | Biotechnology | Corporate Officer/Principal | |
PROTHENA CORPORATION PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
North American Pharmaceuticals Co. | Chairman | ||
University of Colorado Boulder | College/University | Doctorate Degree | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Investment Managers | Consultant / Advisor | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
METAGENOMI, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 45 |
India | 2 |
Canada | 2 |
Ireland | 2 |
Sectoral
Health Technology | 27 |
Consumer Services | 12 |
Commercial Services | 4 |
Finance | 3 |
Operational
Director/Board Member | 64 |
Corporate Officer/Principal | 39 |
Independent Dir/Board Member | 27 |
Undergraduate Degree | 17 |
General Counsel | 14 |
Most connected contacts
Insiders | |
---|---|
Scott Braunstein | 26 |
Tim Mayleben | 18 |
Elan Ezickson | 17 |
Seth Fischer | 17 |
Sarah Noonberg | 17 |
Martha Manning | 13 |
Sara Nochur | 11 |
Christine Silverstein | 10 |
Steven Pfanstiel | 8 |
Joseph Hulihan | 7 |
Sonya Weigle | 7 |
Michael S. Saporito | 6 |
Christy Shafer | 5 |
Marvin Johnson | 5 |
Charles Austin | 4 |
- Stock Market
- Insiders
- Kimberly McCormick
- Company connections